ACM Research Q2 2026: A Product-Mix Transition, Not a Demand Surge

ACM Research reported Q2 2026 revenue of $292.9 million, a 36% year-over-year increase that sent shares up 15.8% and prompted the company to raise full-year guidance to $1.125 billion–$1.175 billion. Electroplating (ECP) surged 168%. Advanced packaging jumped 153%. Management cited strong order activity, a $4 billion long-term revenue target, and the milestone of shipping its 2,000th electroplating chamber.

The headline numbers tell a demand story. The segment breakdown tells a different one. ACM Research's legacy cleaning business—the category that carried 72% of revenue just one year ago—declined 14% year-over-year in Q2 2026. The 36% top-line growth is not a broad-based expansion. It is a product-mix pivot, and the margin, inventory, and cash-flow mechanics of that pivot have not yet been fully reflected in the stock.

The Revenue Split: What's Growing and What's Shrinking

The data below shows the shift.

Segment	Q2 2025 Revenue	Q2 2026 Revenue	YoY Change	Share of Revenue (Q2 2025)	Share of Revenue (Q2 2026)
Single wafer & Tahoe cleaning	$155.0M	$133.0M	-14.2%	72%	45%
ECP, furnace & other	$48.0M	$128.5M	+167.7%	22%	44%
Advanced packaging (excl. ECP)	$12.4M	$31.4M	+153.3%	6%	11%
Total	$215.4M	$292.9M	+36.0%	100%	100%

The cleaning decline is the structural signal. ACM Research built its business on single-wafer and Tahoe cleaning equipment. That category has been ACMR's durable cash engine and its primary source of market share gains in China. A 14% contraction means the company's core installed base and repeat-order cycle is under pressure, at least in the short term. Management attributed the decline to the timing of new SPM (single plasma megasonic) tool revenue recognition—only a handful of SPM units shipped in H1 2026, and SPM represents roughly one-third of the total cleaning market. More than 20 SPM tools are expected to ship in H2. That timeline matters, but it also means the cleaning rebound is deferred, not immediate.

Meanwhile, the ECP and advanced packaging categories that are carrying total revenue growth are still in their commercial ramp. The ECP segment crossed $128 million in a single quarter for the first time, but it is a lower-margin category in its early qualification phase. The implication is straightforward: ACM Research is trading a mature, higher-margin cleaning business for a fast-growing, lower-margin electroplating and packaging mix.

Margin and Inventory: The Cost of Transition

Gross margin fell to 46.0% in Q2 2026, down from 48.7% a year ago. The company maintains a long-term target range of 42%–48%, and 46.0% sits inside that band. But the compression is not noise. It reflects two forces: rising component costs and the shift toward new product categories that carry lower initial margins. Management noted that component lead times have stretched from four months to six months, particularly for parts sourced from Japan and Korea. Suppliers are delaying shipments rather than raising prices—at least for now—but the constraint is real and it will test pricing discipline if it persists.

Inventory is where the transition becomes visible. Net inventory reached $783.1 million at the end of Q2, up from roughly $738 million trailing twelve months. The composition tells the story: raw materials of $406.1 million, work in progress of $89.0 million, and finished goods of $287.9 million.

The $288 million in finished goods is the critical line item. Management explained that most of it consists of first tools sitting at customer sites under evaluation, not unsold backlog. That is functionally accurate but also a distinction without a difference from a cash-conversion standpoint: tools at customer sites are not generating revenue until acceptance occurs, and acceptance cycles can extend unpredictably. Shipment growth is expected to outpace revenue growth in 2026, which is management's way of acknowledging that the gap between tools delivered and revenue recognized will widen through the second half.

Customer concentration has improved—one customer accounted for 12.7% of H1 2026 revenue, compared to three customers representing 49.9% in H1 2025. That deconcentration is a positive sign of a broader customer base, but it does not offset the inventory build or the margin compression during the product-mix transition.

Cash Flow and Capex: Burning Through the Transition

The balance sheet remains solid. Net cash was $1.0 billion at June 30, 2026, with total cash, equivalents, and time deposits at $1.36 billion. Approximately $300 million of that is held on the U.S. balance sheet following a May 2026 registered direct offering.

But free cash flow is deeply negative. Trailing twelve-month free cash flow came in at -$119.8 million, a decline of 579% year-over-year. Operating cash flow for the TTM period was -$6.6 million, against capital expenditures of $113.2 million. Full-year 2026 capex is guided at approximately $175 million, and management confirmed on the call that the company expects to burn cash in 2026, with positive cash flow deferred to the longer term.

This is not a margin-cutting cycle. It is a capital-intensive product ramp. The company is simultaneously building out an Oregon demo center (opening Q4 2026), expanding a 1 million-square-foot R&D and production facility in Lingang, China, and qualifying four new product platforms: SPM cleaning, Track, PECVD, and horizontal panel-level plating. The $1.0 billion net cash position provides runway, but it also means the stock is pricing in a successful conversion from cash burn to cash generation before the mechanics of that conversion are proven.

At a $5.79 billion market cap and 63.6x trailing earnings, ACM Research trades at a premium to the semiconductor equipment average despite negative free cash flow and a declining core business. Applied Materials trades at 50.3x PE with positive cash generation and a diversified portfolio. Lam Research is at 53.6x with the same profile. ACMR's valuation assumes the product-mix pivot will execute smoothly, margins will hold within the 42%–48% band, and the cleaning business will stabilize as SPM ramps. Any one of those assumptions slipping extends the cash-burn period and pressures the multiple.

The Panel-Level Gambit

The most forward-looking signal from the quarter was the receipt of two orders for the Ultra ECP ap-p horizontal panel-level electroplating tool: a production order for one 510 × 515 mm tool from an existing advanced packaging customer in mainland China, with delivery scheduled for the first half of 2027, and an evaluation order for one 310 × 310 mm tool from a new leading panel manufacturer in Asia, with delivery in Q4 2026.

Panel-level packaging is the structural play here. As advanced packaging moves beyond wafer-level formats toward larger panels (510 × 515 mm and 600 × 600 mm), horizontal electroplating systems become a requirement for deposition uniformity at scale. ACM Research is positioning itself as the first to commercialize this tool. But the timeline is back-loaded: the production order does not ship until H1 2027, and the evaluation order is still in qualification. Revenue from panel-level plating will not appear on the income statement until those tools are delivered and accepted, which places it well beyond the current guidance window.

Investor Takeaway

ACM Research's Q2 2026 results are not a broad-based demand story. They are a product-mix transition story, and the difference matters. The cleaning business that built the company and carried 72% of revenue a year ago is declining. The growth is entirely from electroplating and advanced packaging categories that are lower-margin in their ramp phase, capital-intensive, and dependent on customer qualification cycles that are extending. Gross margin compressed to 46.0%, inventory swelled to $783 million with $288 million in finished goods sitting at customer sites, and free cash flow is deeply negative at -$120 million trailing twelve months.

The key issue is not whether electroplating and advanced packaging will grow. They will. The more important question is whether ACM Research can execute the transition from its legacy cleaning cash engine to a multi-product portfolio without extending the cash-burn period or compressing margins below the 42% floor. The supply chain constraint—component lead times stretching from four to six months—adds timing risk to revenue recognition. The $300 million in U.S.-held cash provides runway but does not change the underlying cash-flow trajectory.

The stock is up 112% year-to-date and 243% on a rolling annual basis. That run has priced in a smooth transition. If SPM cleaning ramps as expected in H2 2026, if ECP and packaging margin profiles stabilize, and if acceptance delays do not push significant revenue into 2027, the thesis holds. If the cleaning decline persists longer than management expects, or if supply chain constraints delay shipments and compress margins further, the valuation multiple will face pressure. The structural bet is on execution during transition, not on demand.